NeoGenomics, Inc. (NEO)
18.47
+0.69
(+3.88%)
USD |
NASDAQ |
Oct 02, 16:00
18.48
+0.02
(+0.08%)
After-Hours: 20:00
NeoGenomics Enterprise Value : 2.665B for Oct. 2, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 2.665B |
| October 01, 2026 | 2.577B |
| September 30, 2026 | 2.651B |
| September 29, 2026 | 2.700B |
| September 28, 2026 | 2.770B |
| September 25, 2026 | 2.775B |
| September 24, 2026 | 2.805B |
| September 23, 2026 | 2.651B |
| September 22, 2026 | 2.719B |
| September 21, 2026 | 2.786B |
| September 18, 2026 | 2.850B |
| September 17, 2026 | 2.847B |
| September 16, 2026 | 2.726B |
| September 15, 2026 | 2.719B |
| September 14, 2026 | 2.658B |
| September 11, 2026 | 2.518B |
| September 10, 2026 | 2.555B |
| September 09, 2026 | 2.562B |
| September 08, 2026 | 2.549B |
| September 04, 2026 | 2.526B |
| September 03, 2026 | 2.536B |
| September 02, 2026 | 2.529B |
| September 01, 2026 | 2.535B |
| August 31, 2026 | 2.594B |
| August 28, 2026 | 2.612B |
| Date | Value |
|---|---|
| August 27, 2026 | 2.687B |
| August 26, 2026 | 2.525B |
| August 25, 2026 | 2.451B |
| August 24, 2026 | 2.402B |
| August 21, 2026 | 2.475B |
| August 20, 2026 | 2.417B |
| August 19, 2026 | 2.433B |
| August 18, 2026 | 2.337B |
| August 17, 2026 | 2.370B |
| August 14, 2026 | 2.342B |
| August 13, 2026 | 2.399B |
| August 12, 2026 | 2.403B |
| August 11, 2026 | 2.417B |
| August 10, 2026 | 2.430B |
| August 07, 2026 | 2.422B |
| August 06, 2026 | 2.293B |
| August 05, 2026 | 2.315B |
| August 04, 2026 | 2.387B |
| August 03, 2026 | 2.329B |
| July 31, 2026 | 2.259B |
| July 30, 2026 | 2.334B |
| July 29, 2026 | 2.256B |
| July 28, 2026 | 2.017B |
| July 27, 2026 | 1.984B |
| July 24, 2026 | 2.080B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Precipio, Inc. | 41.89M |
| Quest Diagnostics, Inc. | 31.81B |
| Labcorp Holdings, Inc. | 31.60B |
| OPKO Health, Inc. | 1.261B |
| Psychemedics Corp. | -- |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 2.238M |
| Revenue (Quarterly) | 201.66M |
| Total Expenses (Quarterly) | 199.42M |
| EPS Diluted (Quarterly) | 0.0171 |
| Gross Profit Margin (Quarterly) | 44.06% |
| Profit Margin (Quarterly) | 1.11% |
| Earnings Yield | -2.18% |
| Normalized Earnings Yield | -2.077 |